IFAM
RARX

Institutional & Family Asset Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Institutional & Family Asset Management’s Portfolio RARX Stock Details RARX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-36
Closed -$2K – 947
2019
Q4 		$2K Hold
36
– – ﹤0.01% 782
2019
Q3 		$1K Buy
+36
New +$1.07K ﹤0.01% 827

Other funds holding RARX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Institutional & Family Asset Management's RARX Position: Q1 2020 in Review

Institutional & Family Asset Management sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q1 2020, closing a stake of 36 shares — an estimated $2K sold.

Institutional & Family Asset Management first reported a position in RARX in Q3 2019 and held it in 2 quarters. The position peaked at $2K in Q4 2019. 144 funds tracked by Wall St. Rank hold RARX as of Q1 2020.

  • Institutional & Family Asset Management reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Institutional & Family Asset Management sold 36 Ra Pharmaceuticals, Inc. Common Stock shares in Q1 2020, an estimated $2K.
  • Institutional & Family Asset Management first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • Institutional & Family Asset Management's Ra Pharmaceuticals, Inc. Common Stock position peaked at $2K in Q4 2019.
  • 144 funds tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q1 2020.

Based on Institutional & Family Asset Management's 13F filing for Q1 2020, filed 14 May 2020.